Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Calithera Biosciences - 9 Year Stock Price History | CALA

Historical daily share price chart and data for Calithera Biosciences since 2014 adjusted for splits and dividends. The latest closing stock price for Calithera Biosciences as of November 09, 2023 is 0.03.
  • The all-time high Calithera Biosciences stock closing price was 597.00 on December 12, 2014.
  • The Calithera Biosciences 52-week high stock price is 0.50, which is 1566.7% above the current share price.
  • The Calithera Biosciences 52-week low stock price is 0.01, which is 66.7% below the current share price.
  • The average Calithera Biosciences stock price for the last 52 weeks is 0.11.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Calithera Biosciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2023 0.1862 3.0800 3.6200 0.0150 0.0300 -99.08%
2022 5.1405 13.5560 13.5560 1.3650 3.2600 -75.50%
2021 42.4122 54.4000 73.2000 12.4900 13.3040 -86.45%
2020 103.0126 104.6000 157.0000 64.2000 98.2000 -14.01%
2019 93.2333 84.6000 135.0000 50.4000 114.2000 42.39%
2018 115.4311 178.0000 181.0000 72.4000 80.2000 -51.98%
2017 253.2450 72.0000 400.0000 72.0000 167.0000 156.92%
2016 84.8516 148.8000 155.8000 46.0000 65.0000 -57.57%
2015 215.0802 418.0000 488.0000 88.4000 153.2000 -62.08%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $0.010B
Calithera Biosciences, Inc. is a clinical-stage pharmaceutical company. It is focused on discovering and developing small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. The Company's lead product candidate includes CB-839 which is in three Phase I clinical trials for the treatment of patients with solid tumors, leukemias, lymphomas, and multiple myeloma. Calithera Biosciences, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $69.006B 28.36
Chugai Pharmaceutical (CHGCY) Japan $52.738B 22.90
Takeda Pharmaceutical (TAK) Japan $41.871B 6.78
Merck (MKGAF) Germany $20.467B 19.31
Astellas Pharma (ALPMY) Japan $17.138B 24.28
Sandoz Group AG (SDZNY) Switzerland $14.417B 0.00
Shionogi (SGIOY) Japan $14.386B 12.45
Neurocrine Biosciences (NBIX) United States $13.828B 57.43
United Therapeutics (UTHR) United States $11.153B 11.95
Catalent (CTLT) United States $10.126B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.608B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.824B 6.92
Ionis Pharmaceuticals (IONS) United States $6.187B 0.00
Revolution Medicines (RVMD) United States $5.861B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.232B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.072B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.015B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.886B 0.00
Indivior (INDV) United States $2.594B 12.06
Summit Therapeutics (SMMT) United States $2.519B 0.00
Corcept Therapeutics (CORT) United States $2.340B 23.66
Dyne Therapeutics (DYN) United States $2.153B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.946B 0.00
PTC Therapeutics (PTCT) United States $1.931B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.863B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.857B 11.00
Evotec AG (EVO) Germany $1.853B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.816B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.784B 18.44
Avadel Pharmaceuticals (AVDL) Ireland $1.600B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.586B 27.76
Ardelyx (ARDX) United States $1.496B 0.00
Soleno Therapeutics (SLNO) United States $1.314B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.268B 11.91
4D Molecular Therapeutics (FDMT) United States $1.241B 0.00
Pacira BioSciences (PCRX) United States $1.205B 11.99
Xencor (XNCR) United States $1.163B 0.00
Collegium Pharmaceutical (COLL) United States $1.160B 7.14
Centessa Pharmaceuticals (CNTA) United Kingdom $0.949B 0.00
Cronos Group (CRON) Canada $0.947B 0.00
Cassava Sciences (SAVA) United States $0.897B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.868B 0.00
Sage Therapeutics (SAGE) United States $0.841B 0.00
USANA Health Sciences (USNA) United States $0.841B 13.24
Relay Therapeutics (RLAY) United States $0.840B 0.00
Enliven Therapeutics (ELVN) United States $0.819B 0.00
ARS Pharmaceuticals (SPRY) United States $0.797B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.727B 0.00
Ocular Therapeutix (OCUL) United States $0.719B 0.00
Silence Therapeutics (SLN) United Kingdom $0.667B 0.00
ProKidney (PROK) United States $0.622B 0.00
Siga Technologies (SIGA) United States $0.616B 9.12
Lyell Immunopharma (LYEL) United States $0.586B 0.00
Savara (SVRA) United States $0.586B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.551B 0.00
Verve Therapeutics (VERV) United States $0.550B 0.00
OmniAb (OABI) United States $0.534B 0.00
Korro Bio (KRRO) United States $0.505B 0.00
Altimmune (ALT) United States $0.502B 0.00
Exscientia (EXAI) United Kingdom $0.499B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.445B 0.00
KalVista Pharmaceuticals (KALV) United States $0.437B 0.00
Larimar Therapeutics (LRMR) United States $0.412B 0.00
Lexeo Therapeutics (LXEO) United States $0.412B 0.00
Esperion Therapeutics (ESPR) United States $0.403B 0.00
Heron Therapeutics (HRTX) United States $0.398B 0.00
Tourmaline Bio (TRML) United States $0.395B 0.00
Organogenesis (ORGO) United States $0.393B 74.50
Corbus Pharmaceuticals Holdings (CRBP) United States $0.373B 0.00
Nature's Sunshine Products (NATR) United States $0.367B 20.55
Harrow (HROW) United States $0.363B 0.00
Bioventus (BVS) United States $0.329B 0.00
Lyra Therapeutics (LYRA) United States $0.312B 0.00
Fractyl Health (GUTS) United States $0.301B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.288B 0.00
Akebia Therapeutics (AKBA) United States $0.287B 0.00
Aquestive Therapeutics (AQST) United States $0.286B 0.00
Nanobiotix S.A (NBTX) France $0.278B 0.00
ESSA Pharma (EPIX) Canada $0.277B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.273B 0.00
Black Diamond Therapeutics (BDTX) United States $0.262B 0.00
Xeris Biopharma Holdings (XERS) United States $0.261B 0.00
Pyxis Oncology (PYXS) United States $0.259B 0.00
Nektar Therapeutics (NKTR) United States $0.253B 0.00
Metagenomi (MGX) United States $0.253B 0.00
Adherex Technologies (FENC) United States $0.246B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Conduit Pharmaceuticals (CDT) United States $0.232B 0.00
Foghorn Therapeutics (FHTX) United States $0.222B 0.00
Avita Medical (RCEL) United States $0.221B 0.00
Acrivon Therapeutics (ACRV) United States $0.215B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Prelude Therapeutics (PRLD) United States $0.213B 0.00
Telomir Pharmaceuticals (TELO) United States $0.206B 0.00
Galectin Therapeutics (GALT) United States $0.204B 0.00
Zevra Therapeutics (ZVRA) United States $0.198B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.197B 0.00
Profound Medical (PROF) Canada $0.195B 0.00
Century Therapeutics (IPSC) United States $0.192B 0.00
MediWound (MDWD) Israel $0.167B 0.00
Achieve Life Sciences (ACHV) Canada $0.156B 0.00
CytoDyn (CYDY) United States $0.147B 0.00
Regulus Therapeutics (RGLS) United States $0.145B 0.00
Incannex Healthcare (IXHL) Australia $0.143B 0.00
Elite Pharmaceuticals (ELTP) United States $0.135B 12.63
Amylyx Pharmaceuticals (AMLX) United States $0.127B 2.69
Karyopharm Therapeutics (KPTI) United States $0.127B 0.00
VAXART, INC (VXRT) United States $0.126B 0.00
Inotiv (NOTV) United States $0.120B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
GlycoMimetics (GLYC) United States $0.120B 0.00
Relmada Therapeutics (RLMD) United States $0.116B 0.00
Citius Pharmaceuticals (CTXR) United States $0.114B 0.00
OptiNose (OPTN) United States $0.104B 0.00
Eliem Therapeutics (ELYM) United States $0.101B 0.00
FibroGen (FGEN) United States $0.097B 0.00
Vivani Medical (VANI) United States $0.095B 0.00
ProPhase Labs (PRPH) United States $0.091B 0.00
AlloVir (ALVR) United States $0.090B 0.00
PMV Pharmaceuticals (PMVP) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.084B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
Assertio Holdings (ASRT) United States $0.082B 6.66
Marinus Pharmaceuticals (MRNS) United States $0.079B 0.00
Tempest Therapeutics (TPST) United States $0.076B 0.00
Carisma Therapeutics (CARM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Journey Medical (DERM) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
SCYNEXIS (SCYX) United States $0.057B 0.84
Reneo Pharmaceuticals (RPHM) United States $0.056B 0.00
Gain Therapeutics (GANX) United States $0.052B 0.00
BioLineRx (BLRX) Israel $0.049B 0.00
Jaguar Animal Health (JAGX) United States $0.047B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
JanOne (JAN) United States $0.041B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.036B 0.00
Unicycive Therapeutics (UNCY) United States $0.036B 0.00
ElectroCore (ECOR) United States $0.033B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
CASI Pharmaceuticals (CASI) China $0.033B 0.00
Protara Therapeutics (TARA) United States $0.032B 0.00
NRx Pharmaceuticals (NRXP) United States $0.031B 0.00
Nutriband (NTRB) United States $0.030B 0.00
Surrozen (SRZN) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
DURECT (DRRX) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.025B 0.00
Lipocine (LPCN) United States $0.024B 0.00
Oncternal Therapeutics (ONCT) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 10.73
TherapeuticsMD (TXMD) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
MEI Pharma (MEIP) United States $0.022B 1.10
CERo Therapeutics Holdings (CERO) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Indaptus Therapeutics (INDP) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.019B 0.00
Minerva Neurosciences (NERV) United States $0.018B 0.00
Addex Therapeutics (ADXN) Switzerland $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Traws Pharma (TRAW) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Biomerica (BMRA) United States $0.012B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Cosmos Health (COSM) Greece $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.006B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.29
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.05